NAD Augmentation in Diabetes Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.
Also called NCT05759468
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 156 participants
- Registry
-
NCT05759468
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05759468. Randomized; quadruple masking; primary purpose treatment. Start 2023-04-13 (actual); primary completion 2026-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NAD Augmentation in Diabetes Kidney Disease
- Acronym
- DKD
- Condition
- Type2diabetes
- Condition
- Diabetic Kidney Disease
- Intervention (Drug)
- Investigational Product - MIB 626
- Intervention (Drug)
- Placebo
- Lead sponsor
- Brigham and Women's Hospital
- Collaborator
- Boston Medical Center
Record details
- Record id
cardio:ct-nct05759468- Content hash
876b8d243adcd7efadc9f0ae4dd0645b2a29701900bf7ed458d647e7f2a174c7